% Expired Patents = 14.3

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 169

Loading Chart...

3 inventors (with patents filed for the assignee):

Harrihar A Pershadsingh (7 out of 19 patents)

Mitchell A Avery (3 out of 10 patents)

Theodore W Kurtz (1 out of 6 patents)

7 patents: Sort by Forward Citations

1. 7867991 - Compositions comprising novel PPAR ligands and anti-hyperlipemic agents (2011-01-11),

2. 7812046 - PPAR ligands that do not cause fluid retention, edema or congestive heart failure (2010-10-12),

3. 7339065 - Design and synthesis of optimized ligands for PPAR (2008-03-04),

4. 7232828 - PPAR Ligands that do not cause fluid retention, edema or congestive heart failure (2007-06-19),

5. 6664287 - Antioxidants (2003-12-16),

6. 6369098 - Dithiolane derivatives (2002-04-09),

7. 5824694 - Thiazolidine derivatives for the treatment of psoriasis (1998-10-20),

Company Overview

Bethesda Pharmaceuticals, Inc. is a leading pharmaceutical company dedicated to developing innovative medications to improve the health and well-being of patients worldwide. With a focus on research and development, Bethesda Pharmaceuticals is committed to delivering high-quality and cost-effective solutions to address a wide range of medical needs. Our team of experts is driven by a passion for advancing healthcare and making a positive impact on people's lives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#16 in Bakersfield, CA

#9,508 in California

#39,929 in US

Bakersfield, CA, United States of America

Bethesda Pharmaceuticals, Inc.

Forward Citations = 169

3 inventors:

Harrihar A Pershadsingh (7 out of 19 patents)

Mitchell A Avery (3 out of 10 patents)

Theodore W Kurtz (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bethesda Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/bethesda-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]